肝成纤维细胞

实验要点及说明：

1．本方法适用于贴壁细胞培养，而不适用于悬浮细胞培养，悬浮细胞可使用滴片法； 

2．所使用的盖玻片应该为玻璃**，并经过铬酸洗液处理； 

3．盖玻片非常薄，易碎，取放盖玻片时动作要轻； 

4．如果需要更多生长状态一致的细胞，可以使用较大的培养皿，但不宜过大，以避免培养液的浪费和增加污染机率； 

5．如果细胞贴壁生长能力较差，可将盖玻片在0.5%多聚赖氨酸溶液中浸泡5-10分钟并自然晾干。

培养方法

传代方法 将旧培养液吸除，PBS清洗两遍后，加入6mL（/100mm皿）胰酶，在显微镜下观察，期间禁止摇晃培养皿，细胞刚有脱落时，则吸除大部分胰酶，留约0.5mL，移至培养箱消化，约2min取出。传代用12mL CM1-1培养液终止消化，轻轻吹打均匀细胞，后可分3~6皿培养；

生长条件 37℃，5%CO2，CM1-1培养液。CM1-1培养液：90%DMEM-H+10%FBS。DMEM-H：DMEM高糖培养液，含谷氨酰胺，含丙酮酸钠。

存储条件 冻存则用6mL冻存液（90%FBS+10%DMSO）终止消化，吹打均匀，分为6支冻存管，用程序降温盒于-80℃冻存，过夜转移至液氮中保存。

我司常期代理ATCC Acris  abcam  cst  Biorbyt  santa  Novus  sigma  lifespan  NEB  roche  ABI  R&D millipore   BD  Qiagen Cayman  Jackson Life  GeneTex   Bio-Rad DSHB  tocris   peprotech 等品牌；部分产品现货，超低比价，货期短，价格优，公司产品仅用于科研售后齐全。

培养操作步骤 ：

1．用盖片镊将盖玻片自75%乙醇中取出，用无菌丝绸布擦拭干净，不要用纱布； 

2．将盖玻片轻轻放入6孔培养板（每孔一片）或培养皿中（每个平皿可放置2-3片）； 

3．在距离紫外灯直射范围内20-30 厘米处照射2-3小时； 

4．将经过计数的细胞悬浮液移入培养板中，使盖玻片完全浸在培养液中； 

5．将培养板在5% CO2水浴孵箱中37℃孵育2-3天，当贴壁细胞生长至覆盖培养板底部2/3面积时，将培养板取出，用盖片镊轻轻取出盖玻片，用蒸馏水漂洗后即可进行快速固定以及细胞化学检测。 

细胞培养方法：

1、细胞传代：细胞密度达到80-90%时即可传代

①弃去培养上清，用PBS或生理盐水清洗1-2次；

②加入2ml0.25%胰酶（T25瓶），使胰酶覆盖整个瓶或皿，盖好放入培养箱消化；

③1-2min后，显微镜下观察细胞，若大部分细胞回缩且有少量细胞脱落，轻轻吹打下确认消化情况后加入完全培养基终止消化；若细胞还是贴壁，放回培养箱继续消化至可以轻轻吹打下为止；

④将细胞悬液1000RPM左右条件下离心4min，弃上清；

⑤用新鲜培养基重悬后加入培养瓶或皿中，T25培养瓶加6-8ml培养基；

⑥悬浮细胞直接离心收集，细胞沉淀重悬后分到新培养瓶中。

2、细胞复苏：

①将冻存管在37℃温水中快速摇晃融化，时间1min左右，加入4-5ml培养基混匀。

②在1000RPM左右条件下离心4min，弃上清,加1-2ml培养基吹匀，将细胞悬液加入培养瓶中，补加适量培养基。

3、细胞冻存：待细胞生长状态良好时进行细胞冻存保种

①弃去培养上清，用PBS或生理盐水清洗1-2次，加入1mL 0.25%胰蛋白酶（T25瓶）

②1-2min后，显微镜下观察细胞，大部分细胞回缩且有少量细胞脱落，轻轻吹打下确认消化情况后加入完全培养基终止消化；

③将细胞悬液1000RPM左右条件下离心4min，弃上清，加1ml冻存液重悬细胞；

④将冻存管放入程序降温盒，放入-80℃冰箱，4小时后将冻存管转入液氮罐储存。

Function : Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling.

Subunit : Heterodimer of a regulatory subunit PIK3R1 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts with FER. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated). Interacts with PTK2/FAK1. Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with LYN (via SH3 domain); this enhances enzyme activity. Interacts with phosphorylated LAT, LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV. Interacts with HCV NS5A. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4, as well as with NISCH and HCST. Interacts with FASLG, KIT and BCR. Interacts with AXL, FGFR1, FGFR2, FGFR3 and FGFR4 (phosphorylated). Interacts with FGR and HCK. Interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with ERBB4 (phosphorylated). Interacts with NTRK1 (phosphorylated upon ligand-binding).

Tissue Specificity : Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).

Post-translational modifications : Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.

Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear. Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.

Similarity : Belongs to the PI3K p85 subunit family.

Contains 1 Rho-GAP domain.

Contains 2 SH2 domains.

Contains 1 SH3 domain.

英文名称  Anti-phospho-PIK3R1(Tyr556)

中文名称  磷酸化磷脂酰肌醇激酶抗体

别    名  PIK3R1(phospho Y556); GRB1; p50 alpha; p55 alpha; p85 alpha; p85; Phosphatidylinositol 3 kinase associated p85 alpha; Phosphatidylinositol 3 kinase regulatory 1; Phosphatidylinositol 3 kinase regulatory alpha subunit; Phosphoinositide 3 kinase regulatory subunit polypeptide 1 (p85 alpha); PI3 kinase p85 alpha subunit; PI3 kinase p85 subunit alpha; PI3K ; PIK3R1; PtdIns 3 kinase p85 alpha.

浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit  

克隆类型  polyclonal

交叉反应  Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig

产品类型  一抗  磷酸化抗体   
肝成纤维细胞肿瘤坏死因子α检测试剂盒氟化，无水 SP氯亚钯酸铵 Pd ≥36.5%

肿瘤坏死因子α诱导蛋白6检测试剂盒氟化，无水 99.9% metals basis氯铱酸铵 铱含量：43.0%

肿瘤坏死因子α转化酶检测试剂盒氟化，无水 AR，颗粒氧化金 金含量≥88.6 %

肿瘤坏死因子β检测试剂盒氟化，无水 电子级，粉末反式-双(三苯基膦)合氯化羰基铑(Ⅰ) Rh 14.91%

肿瘤坏死因子γ检测试剂盒13-乙酰基-9-羟基巴卡丁III 分析标准品，≥99%双(苯)二氯铂(II) Pt ≥41.0%

肿瘤坏死因子可溶性受体Ⅰ检测试剂盒13-乙酰基-9-羟基巴卡丁III 99%二氯二氨钯 Pd ≥50%

肿瘤坏死因子可溶性受体Ⅱ检测试剂盒10-脱乙酰基巴卡丁 III 95%氯铱酸 Ir 35% in HCl